RNF8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.278000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.281400E-01
Normal-vs-Stage2
6.548600E-01
Normal-vs-Stage3
1.816390E-01
Normal-vs-Stage4
4.325200E-01
Stage1-vs-Stage2
6.120400E-01
Stage1-vs-Stage3
1.614010E-01
Stage1-vs-Stage4
3.156000E-01
Stage2-vs-Stage3
1.553180E-01
Stage2-vs-Stage4
3.317800E-01
Stage3-vs-Stage4
1.497450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.770400E-01
Normal-vs-AfricanAmerican
3.441400E-01
Normal-vs-Asian
2.752000E-01
Caucasian-vs-AfricanAmerican
5.127200E-01
Caucasian-vs-Asian
2.358600E-01
AfricanAmerican-vs-Asian
8.053400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.328000E-01
Normal-vs-Female
7.283200E-01
Male-vs-Female
9.610000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.467800E-01
Normal-vs-Age(41-60Yrs)
8.660400E-01
Normal-vs-Age(61-80Yrs)
5.134800E-01
Normal-vs-Age(81-100Yrs)
9.066600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.092200E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.037900E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.862600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.559700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.807600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.352370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.586400E-01
Normal-vs-Daily Drinker
2.463200E-01
Normal-vs-Weekly Drinker
9.649000E-01
Normal-vs-Occasional Drinker
4.944800E-01
Normal-vs-Social Drinker
7.444000E-01
Non Drinker-vs-Daily Drinker
5.732200E-01
Non Drinker-vs-Weekly Drinker
1.046580E-01
Non Drinker-vs-Occasional Drinker
2.421600E-03
Non Drinker-vs-Social Drinker
2.619800E-01
Daily Drinker-vs-Weekly Drinker
5.567700E-02
Daily Drinker-vs-Occasional Drinker
1.402390E-03
Daily Drinker-vs-Social Drinker
1.275430E-01
Weekly Drinker-vs-Occasional Drinker
2.930400E-01
Weekly Drinker-vs-Social Drinker
5.885800E-01
Occasional Drinker-vs-Social Drinker
8.508500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.570800E-01
Normal-vs-Grade 2
9.020200E-01
Normal-vs-Grade 3
8.616000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.695600E-01
Grade 1-vs-Grade 3
1.618810E-01
Grade 1-vs-Grade 4
9.570800E-01
Grade 2-vs-Grade 3
3.825000E-01
Grade 2-vs-Grade 4
9.020200E-01
Grade 3-vs-Grade 4
8.616000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.683800E-01
Normal-vs-NonDiabetic
6.580800E-01
Diabetic-vs-NonDiabetic
8.509000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.842800E-01
Normal-vs-NoPancreatitis
7.374000E-01
Pancreatitis-vs-NoPancreatitis
3.098600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.972800E-01
Normal-vs-N1
7.151200E-01
N0-vs-N1
8.856200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.429600E-01
Normal-vs-TP53-NonMutant
3.008000E-01
TP53-Mutant-vs-TP53-NonMutant
6.413800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
